$CBRS

Lie Sean sold $151.1M of CBRS

Lie Sean (Chief Technology Officer) sold 726,540 shares of Cerebras Systems Inc. (CBRS) at an average of $207.90 ($203.78–$212.64, $151.05M total) across 11 trades over 2026-08-20 to 2026-08-21 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Lie Sean
Published Aug 22, 2026, 12:58 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 22, 2026, 1:07 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CBRS
Bearish
high confidence
Mentioned
$CBRS
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSBearishMed
01

Why it matters

The $151M sale reduces insider ownership and may be interpreted as a negative signal, but could also be a scheduled liquidity event.

02

Market read

Primary insider sale provides fresh material for traders; relevance is moderate to high for short‑term positioning.

03

What to watch

Potential upcoming product launch or financing event that prompted the pre‑arranged sale.

Relevance 7/10Novelty 8/10Timing: filing disclosed today (2026‑08‑22)

Background

SEC Form 4 filing discloses an insider transaction by Cerebras CTO Lie Sean.

Company-level read

Ticker impact

$CBRSBearishHigh confidence
Context

CTO Lie Sean sold 726,540 shares for $151.1M via a 10b5‑1 plan, reducing his stake to 368,926 shares.

Expected impact

Possible short‑term dip of 2‑4% as market digests the sizable sale.

Evidence & confidence

The sale size ($151M) is material for a mid‑cap AI chip maker; insider sales often precede price weakness.

Market effects

May raise concerns for AI‑hardware sector if other insiders follow suit.

Limited to US tech equities; no broader regional effect.

Minimal global impact beyond investors tracking Cerebras.

Counterpoint

The sale could be a routine 10b5‑1 execution unrelated to fundamentals.

Key entities

  • Cerebras Systems Inc.

    AI chip maker listed on NASDAQ (CBRS).

  • Lie Sean

    Chief Technology Officer of Cerebras.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBRSMed

Cerebras stock jumps 9%; Q3 sales guide sets a harder test

Cerebras Systems (CBRS) stock rose 9% after OpenAI's Sam Altman reaffirmed their partnership. The company's Q3 revenue guidance suggests 2.4% sequential growth. OpenAI committed to 750MW of capacity, with an option for 1.25GW. Cerebras reported $56.8M in OpenAI-related revenue in Q2, 31.5% of total GAAP revenue. The stock remains below its IPO price of $185.

$CBRSHigh

CBRS Stock Surges Over 6% in Monday Pre-Market: What's the Sam Altman Connection? - Cerebras Systems (NAS

Cerebras Systems (CBRS) shares rose 6.56% premarket after OpenAI CEO Sam Altman called it a 'close partner,' easing concerns. Analysts noted strong ties with OpenAI, despite Nvidia (NVDA) running its new model. Barclays' Tom O'Malley called the sell-off 'overdone,' while Paul Meeks upgraded CBRS to Buy with a $209 target, citing high AI demand. CBRS is down 52.45% YTD.

$CBRSMed

Mizuho reiterates Cerebras Systems stock rating on inference growth

Mizuho reiterated its Outperform rating and $300 price target for Cerebras Systems (CBRS), citing growth in fast inference workloads. The firm projects a $550B market by 2030, with CBRS trading near its 52-week low at $166.43. CBRS reported 91% revenue growth over the last year, and analysts have revised earnings upwards, though some suggest overvaluation. The company unveiled the CS-4 system, with improved performance and compute density, expected in Q3.